Apollo Medical Holdings Inc (NASDAQ:AMEH) Director Mark Fawcett acquired 10,000 shares of the stock in a transaction on Tuesday, June 11th. The shares were purchased at an average price of $14.13 per share, for a total transaction of $141,300.00. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Shares of AMEH traded up $1.08 during trading hours on Friday, hitting $16.11. 11,282 shares of the company were exchanged, compared to its average volume of 107,400. The firm has a market cap of $526.15 million, a P/E ratio of 55.55, a price-to-earnings-growth ratio of 4.33 and a beta of -0.74. Apollo Medical Holdings Inc has a fifty-two week low of $13.36 and a fifty-two week high of $30.00. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.00 and a current ratio of 2.00.
Apollo Medical (NASDAQ:AMEH) last released its earnings results on Monday, March 18th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.20). The company had revenue of $105.46 million for the quarter. Apollo Medical had a return on equity of 4.87% and a net margin of 1.79%. On average, research analysts predict that Apollo Medical Holdings Inc will post 0.34 earnings per share for the current fiscal year.
Several research firms have weighed in on AMEH. ValuEngine cut Apollo Medical from a “buy” rating to a “hold” rating in a research report on Thursday, June 6th. Zacks Investment Research upgraded Apollo Medical from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 28th.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. ExodusPoint Capital Management LP bought a new position in Apollo Medical during the 1st quarter valued at approximately $208,000. Geode Capital Management LLC raised its position in Apollo Medical by 3.3% during the 1st quarter. Geode Capital Management LLC now owns 189,445 shares of the company’s stock valued at $3,470,000 after purchasing an additional 6,000 shares during the last quarter. Northern Trust Corp raised its position in Apollo Medical by 5.9% during the 1st quarter. Northern Trust Corp now owns 118,464 shares of the company’s stock valued at $2,171,000 after purchasing an additional 6,581 shares during the last quarter. Swiss National Bank raised its position in Apollo Medical by 5.0% during the 1st quarter. Swiss National Bank now owns 46,644 shares of the company’s stock valued at $855,000 after purchasing an additional 2,200 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Apollo Medical by 17.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 37,750 shares of the company’s stock valued at $692,000 after purchasing an additional 5,508 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors.
About Apollo Medical
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
See Also: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.